The study of stem cells has shattered the concept of strict cell lineage restriction, has provided promising approaches to regeneration and has given a new perspective on the causes and treatments of cancers. The intent of the Stem Cell and Cancer Biology (SCCB) training grant at New York University School of Medicine is to provide training in this rapidly developing research field. It is our explicit goal to empower trainees with a deep understanding of the methods, principles and questions that provide the base of this new and likely transformative research area. Specifically, the SCCB program aims to train students and postdoctoral fellows in the fields of normal and cancer stem cell biology in order to elucidate mechanisms and pathways that when activated in an inappropriate manner in stem/progenitor cells contribute to malignant transformation. A long- term goal of the program is to train a new cadre of researchers whose broad and interdisciplinary knowledge of stem cell and cancer biology may result in a better understanding of the causes of cancer that may eventually lead to the development of new targeted therapies to treat tumors. The SCCB program focuses on enabling trainees to acquire the skills needed for successful careers as independent scientists in the cancer stem cell biology field by empowering them to develop independent and rigorous critical skills. The 16 SCCB mentors are highly productive scientists most of whom have NCI and other cancer related funding. They have trained a total of 72 students and 96 post-doctoral fellows in the past 10 years. The SCCB program will provide intellectually demanding pre- and postdoctoral training in a highly interactive scientific environment providing rigorous courses, tutorials, and seminars in a broad training environment that encourages diversity. Multi-tiered mentoring plans will allow monitoring of research progress. Trainees will also acquire the ability to critically evaluate scientific data and literature and will develop their writing and presentation skills. Training of students will include rigorous courses in Stem Cell Biology, Genetics and Molecular Oncology. All trainees will participate in the stem cell biology seminar series, an annual retreat, journal clubs and discussion groups as well as lectures focusing on ethical conduct in science and career options. Funds are requested to support 2 pre- and 4 postdoctoral trainees out of a total trainee group of 33 eligible pre- (based on 2009 admissions) and 110 eligible postdoctoral trainees (based on current postdoctoral trainee totals). These trainees will represent a new generation of scientists who can contribute to the development of novel therapies to treat malignant diseases.

Public Health Relevance

This training program proposes to train pre- and postdoctoral students/fellows in the fields of normal and cancer stem cell biology in order to elucidate mechanisms and pathways that when activated in an inappropriate manner in stem/progenitor cells contribute to malignant transformation. Findings from these studies will contribute to a better understanding of the causes of cancer that may lead to the development of new targeted therapies to treat malignancies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA160002-02
Application #
8305513
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
2011-09-01
Project End
2016-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
2
Fiscal Year
2012
Total Cost
$285,944
Indirect Cost
$19,196
Name
New York University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Chang, Jessica B; Rifkin, William J; Soares, Marc A et al. (2018) Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival. Plast Reconstr Surg Glob Open 6:e1825
Pae, Juhee; Cinalli, Ryan M; Marzio, Antonio et al. (2017) GCL and CUL3 Control the Switch between Cell Lineages by Mediating Localized Degradation of an RTK. Dev Cell 42:130-142.e7
Soares, Marc A; Cohen, Oriana D; Low, Yee Cheng et al. (2016) Restoration of Nrf2 Signaling Normalizes the Regenerative Niche. Diabetes 65:633-46
Murphy, Matthew; Chatterjee, Sujash S; Jain, Sidharth et al. (2016) TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3. Sci Rep 6:28299
Gao, Jie; Buckley, Shannon M; Cimmino, Luisa et al. (2015) The CUL4-DDB1 ubiquitin ligase complex controls adult and embryonic stem cell differentiation and homeostasis. Elife 4:
Murtha, Matthew; Strino, Francesco; Tokcaer-Keskin, Zeynep et al. (2015) Comparative FAIRE-seq analysis reveals distinguishing features of the chromatin structure of ground state- and primed-pluripotent cells. Stem Cells 33:378-91
Chatterjee, Sujash S; Saj, Abil; Gocha, Tenzin et al. (2015) Inhibition of ?-catenin-TCF1 interaction delays differentiation of mouse embryonic stem cells. J Cell Biol 211:39-51
Gao, Zhonghua; Lee, Pedro; Stafford, James M et al. (2014) An AUTS2-Polycomb complex activates gene expression in the CNS. Nature 516:349-54
Murtha, Matthew; Tokcaer-Keskin, Zeynep; Tang, Zuojian et al. (2014) FIREWACh: high-throughput functional detection of transcriptional regulatory modules in mammalian cells. Nat Methods 11:559-65
Reavie, Linsey; Buckley, Shannon M; Loizou, Evangelia et al. (2013) Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell 23:362-75

Showing the most recent 10 out of 11 publications